Transepithelial transport across Caco-2 cell monolayers of antihypertensive egg-derived peptides. PepT1-mediated flux of Tyr-Pro-Ile

Molecular Nutrition and Food Research

Volumn 52, Issue 12, 2008, Pages 1507-1513

  Miguel, Marta ^a   Dávalos, Alberto ^b   Manso, María A ^a   De La Peña, Gema ^b   Lasunción, Miguel A ^b,c,d   López Fandiño, Rosina ^a  

^a INSTITUTO DE FERMENTACIONES INDUSTRIALES CSIC   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antihypertensive peptides; Caco 2 cells; Egg proteins; Intestinal transport

Indexed keywords

ANTIHYPERTENSIVE AGENT; COTRANSPORTER; EGG PROTEIN; OLIGOPEPTIDE; SLC15A1 PROTEIN, HUMAN;

ARTICLE; CELL STRAIN CACO 2; HUMAN; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANTIHYPERTENSIVE AGENTS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; EGG PROTEINS; HUMANS; INTESTINAL MUCOSA; OLIGOPEPTIDES; SYMPORTERS;

EID: 57549088511     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700503     Document Type: Article

References (40)

1. Korhonen, H., Pihlanto, A., Bioactive peptides: Production and functionality. Int. Dairy J. 2006, 16, 945-960.
2. Vermeirssen, V., Van Camp, J., Verstraete, W., Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br. J. Nutr. 2004, 92, 357-366.
3. Vermeirssen, V., Van Camp, J., Decroos, K., Van Wijmelbeke, L., Verstraete, W., The impact of fermentation and in vitro digestion on the formation of angiotensin-I-converting enzyme inhibitory activity from pea and whey protein. J. Dairy Sci. 2003, 86, 429-438.
4. Aleixandre, A., Miguel, M., Antihypertensive peptides from egg white proteins. J. Nutr. 2006, 136, 1457-1460.
5. Vermeirssen, V., Deplancke, B., Tappenden, K.-A., Van Camp, J. et al., Intestinal transport of the lactokinin Ala-Leu-ProMet-His-Ile-Arg through a Caco-2 monolayer. J. Pept. Sci. 2002, 8, 95-100.
6. Pihlanto-Leppälä, A., Bioactive peptides derived from bovine whey proteins: Opioid and ACE-inhibitory peptides. Trends Food Sci. Technol. 2001, 11, 347-356.
7. Brodin, B., Nielsen, C.-U., Steffansen, B., Frøkjaer, S., Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1. Pharmacol. Toxicol. 2002, 90, 285-296.
8. Amidon, G.-L., Lee, H.-J., Absorption of peptide and peptidomimetic drugs. Annu. Rev. Pharmacol. Toxicol. 1994, 34, 321-341.
9. Shu, C., Shen, H., Hopfer, U., Smith, D.-E., Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: Uptake and transport of fosinopril in cell cultures. Drug Metab. Dispos. 2001, 29, 1307-1315.
10. Satake, M., Enjoh, M., Nakamura, Y., Takano, T., et al., Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci. Biotechnol. Biochem. 2002, 66, 378-384.
11. Masuda, O., Nakamura, Y., Takano, T., Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr. 1996, 126, 3063-3068.
12. Shen, W. C., Wan, J., Ekrami, H., Enhancement of polypeptide and protein absorption by macromolecular carriers via endocytosis and transcytosis. Adv. Drug Deliv. Rev. 1992, 8, 93-113.
13. Pappenheimer, J.-R., Dahl, C.-E., Karnovsky, M.-L., Maggio, J.-E., Intestinal absorption and excretion of octapeptides composed of D amino acids. Proc. Natl. Acad. Sci. USA 1994, 91, 1942-1945.
14. Shimizu, M., Tsunogai, M., Arai, S., Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides 1997, 18, 681-687. Erratum in: Peptides 1998, 19, 791.
15. Fujita, H., Usui, H., Kurahashi, K., Yoshikawa, M., Isolation and characterization of ovokinin, a bradykinin B1 agonist peptide derived from ovalbumin. Peptides 1995, 16, 785-790.
16. Miguel, M., Recio, I., Gómez-Ruiz, J.-A., Ramos, M., López-Fandiño, R., Angiotensin I-converting enzyme inhibitory activity of peptides derived from egg white proteins by enzymatic hydrolysis. J. Food Prot. 2004, 67, 1914-1920.
17. Miguel, M., López-Fandiño, R., Ramos, M., Aleixandre, A., Short-term effect of egg-white hydrolysate products on the arterial blood pressure of hypertensive rats. Br. J. Nutr. 2005, 94, 731-737.
18. Miguel, M., Aleixandre, M.-A., Ramos, M., López-Fandiño, R., Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin. J. Agric. Food Chem. 2006, 54, 726-731.
19. Miguel, M., Álvarez, Y., López-Fandiño, R., Alonso, M.-J., Salaices, M., Vasodilator effects of peptides derived from egg white proteins. Regul. Pept. 2007, 140, 131-135.
20. Bernasconi, E., Fritsche, R., Corthesy, B., Specific effects of denaturation, hydrolysis and exposure to Lactococcus lactis on bovine beta-lactoglobulin transepithelial transport, antigenicity and allergenicity. Clin. Exp. Allergy 2006, 36, 803-814.
21. Yamada, Y., Matoba, N., Usiu, H., Onishi, K., Yoshikawa, M., Design of a highly potent anti-hypertensive peptide based on Ovokinin(2-7). Biosci. Biotechnol. Biochem. 2002, 66, 1213-1217.
22. Scruggs, P., Filipeanu, C.-M., Yang, J., Chang, J.-K., Dun, N.-J., Interaction of ovokinin(2-7) with vascular bradykinin 2 receptors. Regul. Pept. 2004, 120, 85-91.
23. Fujita, H., Sasaki, R., Yoshikawa, M., Potentiation of the antihypertensive activity of orally administerd Ovokinin, a vasorelaxing peptide derived from ovalbumin, by emulsification in egg phosphatidyl-choline. Biosci. Biotech. Biochem. 1995, 59, 2344-2345.
24. Matoba, N., Usui, H., Fujita, H., Yoshikawa, M., A novel antihypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett. 1999, 452, 181-184.
25. Rangachari, P.-K., Berezin, M., Prior, T., Effects of bradykinin on the canine proximal colon. Regul. Pept. 1993, 46, 511-522.
26. Quirós, A., Dávalos, A., Lasunción, M.-A., Ramos, M., Recio, I., Bioavailability of the antihypertensive peptide LHLPLP: Transepithelial flux of HLPLP. Int. Dairy J. 2008, 18, 279-286.
27. Irie, M., Terada, T., Okuda, M., Inui, K., Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2. Pflugers Arch. 2004, 449, 186-194.
28. Terada, T., Sawada, K., Saito, H., Hashimoto, Y., Inui, K., Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2. Am. J. Physiol. 1999, 276, G1435-G1441.
29. Thwaites, D.-T., Cavet, M., Hirst, B.-H., Simmons, N.-L., Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2. Br. J. Pharmacol. 1995, 114, 981-986.
30. Zhu, T., Chen, X.-Z., Steel, A., Hediger, M. A., Smith, D. E., Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2. Pharm. Res. 2000, 17, 526-532.
31. Madara, J.-L., Barenberg, D., Carlson, S., Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: Further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J. Cell Biol. 1986, 102, 2125-2136.
32. Hansen, S.-H., Olsson, A., Casanova, J.-E., Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcytosis in polarized epithelial cells. J. Biol. Chem. 1995, 270, 28425-28432.
33. Dyer, J., Beechey, R. B., Gorvel, J.-P., Smith, R.-T., et al., Glycyl-L-Proline transport in rabbit enterocyte basolateral-membrane vesicles. Biochem. J. 1990, 269, 565-571.
34. Saito, H., Inui, K., Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am. J. Physiol. 1993, 265, G289-G294.
35. Grimble, G.-K., Mechanisms of peptide and amino acid transport and their regulation. in: Furst, P., Young, V. (Eds.), Proteins, Peptides and Amino Acids in Enteral Nutrition, Nestle Nutrition Workshop Series Clinical & Performance Program. Nestec Ltd., Basel, 2000, pp. 63-88.
36. Matthews, D. M., Payne, J. W., Transmembrane transport of small peptides. in: Bronner, F., Kleinzeller, A. (Eds.), Current Topics in Membrane and Transport, Academic Press, New York 1980, pp. 331-425.
37. Aito-Inoue, M., Lackeyram, D., Fan, M.-Z., Sato, K., Mine, Y., Transport of a tripeptide, Gly-ProHyp, across the porcine intestinal brush-border membrane. J. Pept. Sci. 2007, 13, 468-474.
38. Vermeirssen, V., Augustijns, P., Morel, N., Van Camp, J., et al., In vitro intestinal transport and antihypertensive activity of ACE inhibitory pea and whey digests. Int. J. Food Sci. Nutr. 2005, 56, 415-430.
39. Föger, F., Kopf, A., Loretz, B., Albrecht, K., Bernkop- Schnürch, A., Correlation of in vitro and in vivo models for the oral absorption of peptide drugs. Amino Acids 2008, 348, 169-174.
40. Geerlings, A., Villar, I.-C., Hidalgo Zarco, F., Sánchez, M. et al., Identification and characterization of novel angiotensin-onverting enzyme inhibitors obtained from goat milk. J. Dairy Sci. 2006, 89, 3326-3335.